Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus — I-Seizure

Refractory Status Epilepticus Clinical Trial

Official title:
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus (I-Seizure)

Status Not yet recruiting

Clinical Trial Summary

Isoflurane might be used as anticonvulsive therapy in refractory status epilepticus. The aim of the study is to assess the efficiency of Isoflurane in this indication.

Clinical Trial Description

Investigators will collect in 4 ICUs the data from consecutive patients hospitalized between january 2016 and january 2023. Included patient were those treated by Isoflurane for refractory status epilepticus. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05830864
Study type	Observational [Patient Registry]
Source	Hopital of Melun
Contact	SEBASTIEN JOCHMANS, MD
Phone	0181742078
Email	sebastien.jochmans@ghsif.fr
Status	Not yet recruiting
Phase
Start date	March 1, 2024
Completion date	December 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01796574` - Ketogenic Diet for Refractory Status Epilepticus	N/A
Recruiting	`NCT06344338` - Application of tDCS Stimulation in Controlling Refractory Status Epilepticus	N/A
Withdrawn	`NCT05814523` - To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)	Phase 3
Not yet recruiting	`NCT05684978` - Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus	Phase 4
Recruiting	`NCT05851391` - buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest	Phase 2
Recruiting	`NCT05934903` - Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus	N/A
Completed	`NCT04333082` - Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction